Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04359732 | Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI(Escape) | completed | N/A | 121 | IRCCS San RaffaeleOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT04477759 | Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer(DEHART) | completed | Phase 1 | 18 | Medical College of WisconsinOTHER | 1 | Sep 21, 2026 |
| clinicaltrials |
| NCT04512209 | Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology(DCE-MRI) | completed | N/A | 22 | University Hospital, GhentOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT04906187 | Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery(MONIALC) | completed | N/A | 126 | Institut BergoniéOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT04977167 | Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 24 | HitGen Inc.INDUSTRY | 1 | Sep 21, 2026 | clinicaltrials |
| NCT05153239 | Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) | completed | Phase 3 | 705 | PharmaMarINDUSTRY | 24 | Sep 21, 2026 | clinicaltrials |
| NCT05297903 | XmAb20717 in Advanced Biliary Tract Cancers | completed | Phase 2 | 27 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT05359211 | NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma | completed | Phase 1 | 27 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT05812040 | Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge | completed | N/A | 134 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT06014086 | Intratumoral PH-762 for Cutaneous Carcinoma | completed | Phase 1 | 22 | Phio Pharmaceuticals Inc.INDUSTRY | 1 | Sep 21, 2026 | clinicaltrials |
| NCT06137833 | Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy | completed | N/A | 92 | Pharmanutra S.p.a.INDUSTRY | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07338721 | Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer? | completed | — | 100 | Antalya Training and Research HospitalOTHER_GOV | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07550764 | Effect of Infrared-Assisted Intravenous Catheterization on Patient Comfort and Nurse-Patient Trust in Lung Cancer Patients | completed | N/A | 160 | Ataturk UniversityOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07829900 | First-Line Dual Versus Single HER2-Targeted Therapy With Docetaxel for Advanced HER2-Positive Breast Cancer | completed | — | 2,250 | Xin LiOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07830147 | HAIC Rechallenge in Biliary Tract Cancer and Colorectal Cancer Liver Metastases: Efficacy and Safety in Patients Resistant to Previous Systemic Chemotherapy | completed | — | 72 | West China HospitalOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07831083 | Skin Cancer Among Outdoor Workers(Skin Cancer Am) | completed | — | 10,000 | Assuta Medical CenterOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07831460 | Horse-assisted Interventions in an Oncological Centre(ISACCO) | completed | N/A | 28 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07831694 | Postoperative Outcomes After Partial Duodenopancreatectomy Versus Total Pancreatectomy | completed | — | 3,602 | Cantonal Hospital of St. GallenOTHER | 0 | Sep 21, 2026 | clinicaltrials |
| NCT04053842 | Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy(IGPC-5) | completed | Phase 2 | 16 | Glenn BaumanOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT04517708 | Effectiveness of Nutritional Interventions for Cancer Patients Undergoing Chemotherapy | completed | N/A | 120 | Hanoi Medical UniversityOTHER | 0 | Sep 18, 2026 | clinicaltrials |
| NCT04665856 | Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer(SKYSCRAPER-02C) | completed | Phase 3 | 123 | Hoffmann-La RocheINDUSTRY | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05017025 | Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05355363 | Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay(SSL follow-up) | completed | N/A | 727 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05801133 | Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors | completed | Phase 2 | 41 | Hubei Cancer HospitalOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT05971303 | Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies(iCALD-2) | completed | — | 45 | University Health Network, TorontoOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT06007092 | Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer(HPVDCVax) | completed | Phase 1 / Phase 2 | 24 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT06846060 | A Mindfulness-Based Self-Compassion Program | completed | N/A | 64 | Nevsehir Haci Bektas Veli UniversityOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT06863623 | The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients | completed | N/A | 315 | Hacettepe UniversityOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07351474 | Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy | completed | N/A | 147 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07827482 | Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma | completed | — | 228 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07827885 | 20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC(DRAIN2024) | completed | N/A | 80 | Fondazione Policlinico Universitario Campus Bio-MedicoOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07828314 | Patient Priorities in the Management of Early Oesophageal Cancer: A Discrete Choice Study | completed | — | 118 | Portsmouth Hospitals NHS TrustOTHER_GOV | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07828925 | Selective Axillary Dissection After Neoadjuvant Chemotherap Yin Patients With Lymphnode-positive Breast Cancer(CLYP) | completed | — | 105 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT00417495 | Sentinel Lymph Node Technique in Multifocal Breast Cancer(IGASSU) | completed | Phase 2 | 216 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00738868 | Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery(CKNO-RERT) | completed | Phase 2 | 45 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00809016 | PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy(TEPORL) | completed | N/A | 40 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00874874 | Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery(AngioNext) | completed | Phase 2 | 88 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00904410 | Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET(CHIMTEP) | completed | Phase 4 | 63 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00905047 | Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer(COLOCROSS) | completed | Phase 3 | 89 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00911092 | Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer(COL) | completed | Phase 4 | 50 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00911911 | Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy(SPAM) | completed | N/A | 66 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT00963326 | Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer(CARIO) | completed | — | 30 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT01658462 | Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer(VAROCE) | completed | Phase 2 | 51 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT02281149 | Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:(TOMOBREAST) | completed | — | 500 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT02415621 | Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer | completed | Early Phase 1 | 19 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT02704832 | Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)(PREPARE) | completed | N/A | 792 | Institut BergoniéOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT03277638 | Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) | completed | Phase 1 / Phase 2 | 32 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04544748 | A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies | completed | Phase 1 | 48 | AO GENERIUMINDUSTRY | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04556045 | Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer | completed | N/A | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04688151 | Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma. | completed | Phase 1 | 22 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 17, 2026 | clinicaltrials |
Data updated 5 days agoSource updated Sep 21, 2026source: clinicaltrials